This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

BAM15

Newer-generation mitochondrial uncoupler: less fat mass without a rise in body temperature in mice, not studied in humans.

2 min read 9 sources

White capsule bottle with a black TPD label for BAM15 on a white podium, next to it a large blue 3D model of the molecule in a bright lab
Preclinical · not approvedLab tested in the shop

Summary

At a glance

Sources checked on 25 Oct 2026

More potent than DNP in cells
~7 -fold

Cell respiration in mouse liver cells, half-maximal effect at a roughly sevenfold lower concentration1

Half-life (mice)
1.7 hours

after oral dosing, not measured in humans1

Oral bioavailability (mice)
67 %

Share that reaches the blood after oral dosing, compared with dosing into a vein1

Body weight after 5 weeks
-15 %

Mice made obese with a high-fat diet, almost only less fat, same lean mass, same food intake1

Human trials in the registry
0 trials

no trial with BAM15 on ClinicalTrials.gov, as of 25 Oct 20268

  • BAM15 is a small synthetic molecule that acts as a mitochondrial uncoupler: it lets protons flow back past ATP synthase, so the energy is lost as heat.92
  • Unlike DNP, BAM15 does not depolarise the outer cell membrane in cell experiments and was less toxic to cells than the comparison uncoupler FCCP.2
  • In obese mice BAM15 in the food lowered fat mass at the same food intake without changing lean mass or body temperature. The liver stored less fat and insulin action improved.13
  • Further findings come from models of muscle loss in old age, sepsis and acute kidney injury, all in mice.452
  • ClinicalTrials.gov lists no human trial of BAM15 (as of October 2026). Everything here is preclinical research, not a recommendation.8
Profile

Updated June 2026

Class
Mitochondrial uncoupler

protonophore

Use
Oral

1 capsule per day

Half-life
About 1.7 hours in mice

not studied in humans

Status
Preclinical

no human studies

Sizes
50 mg

1 size in the shop

Contents 14 sections
  1. At a glance
  2. What is BAM15?
  3. How it works
  4. BAM15 vs DNP
  5. How to take it
  6. Dosing
  7. What the research shows
  8. Research status
  9. Side effects
  10. Storage
  11. Related compounds
  12. FAQ
  13. Glossary
  14. Sources

What is BAM15?

BAM15 is a synthetic mitochondrial uncoupler. It acts as a protonophore: lets protons flow across the inner mitochondrial membrane without ATP being produced. The energy is dissipated as heat instead - metabolism accelerates.

Same principle as DNP (dinitrophenol), with one difference: BAM15 acts on the mitochondrial membrane and, unlike DNP, does not depolarize the cell's plasma membrane (Kenwood 2014). In cell and animal studies BAM15 was well tolerated; it has not been studied in humans.

How it works

In mitochondria a proton gradient is normally built up that ATP synthase then uses to produce ATP. BAM15 opens an alternative path - protons flow back without making ATP.

Consequence: mitochondria have to work harder to maintain the gradient. More substrate is burned, more heat produced, basal metabolic rate rises markedly. Body weight drops - mostly fat mass.

Where it acts

Where BAM15 acted in experiments

Tap a point or a card. Colour = target, grey = observed. All from cell and mouse studies.

  1. Liver

    Main target: more respiration and fat breakdown, liver fat back to normal on a high-fat diet (mice)1

    Mitochondria
  2. Fat tissue

    Less fat mass and smaller fat depots at the same food intake (mice)1

    Observed in trials
  3. Skeletal muscle

    More muscle share and grip strength in old obese mice4

    Observed in trials
  4. Blood and blood sugar

    Lower triglycerides, better insulin action in the clamp test (mice)1

    Observed in trials
  5. Kidney

    Protection from acute kidney injury after blocked blood flow and in sepsis (mice)5

    Observed in trials
Transparent glass model of a mitochondrion with a folded inner membrane, golden light points streaming out of it, blue 3D molecules beside it
Uncoupling: energy escapes as heat instead of ATP. Symbolic image.

BAM15 vs DNP

DNP is the historical uncoupler: known as a slimming agent since the 1930s, with documented deaths from hyperthermia and no antidote. What sets BAM15 apart in the studies:

  • Plasma membrane: besides the mitochondria, DNP also depolarizes the cell's plasma membrane; BAM15 does not (Kenwood 2014).
  • Concentration range in cells: in mouse liver cells BAM15 raised cellular respiration at a roughly sevenfold lower concentration than DNP and kept it high across a broad range. DNP inhibited respiration above 30 µM (Alexopoulos 2020).
  • Body temperature in mice: BAM15 reduced fat mass without changing body temperature (Alexopoulos 2020).

All of these data come from cells and mice. There is no direct comparison in humans. There are no human studies of BAM15 at all. Whether the wider window from the lab holds in humans is an open question.

Comparison

Uncouplers compared

DNP, BAM15 and the combo with SLU-PP-332, as stated in the TPD lexicon. Tap a card to open its entry.

Simplified: all three act on the mitochondria. DNP also acts on the outer cell membrane, BAM15 does not in cell experiments. There is no comparison in humans. 21

How to take it

Oral capsule, once per day.

  • 1 capsule with some water.
  • Better tolerated with food.
  • Ideally in the morning - mildly activating.
Capsule bottle with a black TPD label for BAM15 next to a glass of water, a bowl of muesli with berries and three white capsules
Taken orally as a capsule, according to the entry easier to tolerate with food. Symbolic image.

Dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts

What the research shows

BAM15 is a preclinical research tool:

  • Kenwood et al. 2014: first characterization as mitochondrial uncoupler, less cytotoxic in cell cultures than the reference uncoupler FCCP.
  • Alexopoulos et al. 2020: clear fat reduction in mouse models without hyperthermia, plus improved insulin sensitivity and fatty liver.

Human studies are missing entirely. Everything is research frontier.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

Mice on a high-fat diet1

Change compared with mice on the same diet without BAM15, in percent

Body weight1 after 5 weeks with BAM15 in the food
Without BAM15 (comparison) 0%
With BAM15 -15%
Blood triglycerides1 at the end of the study
Without BAM15 (comparison) 0%
With BAM15 -29%
Free fatty acids in the liver1 Liver tissue after 5 weeks
Without BAM15 (comparison) 0%
With BAM15 -42%
Oxidised fat (4-HNE) in the liver1 Marker of oxidative stress
Without BAM15 (comparison) 0%
With BAM15 -49%

Values from the results section of the study (full text). Liver triglycerides with BAM15 were back at the level of mice on normal chow. Body temperature, lean mass and liver enzymes did not change. Mouse model, not tested in humans.

More energy use, more fat burning1

Rise compared with the comparison without BAM15, in percent

Oxygen use at night1 BAM15 in the food, active phase of the mice
Without BAM15 (comparison) 0%
With BAM15 15%
Respiration of liver tissue1 one hour after a single dose
Without BAM15 (comparison) 0%
With BAM15 54%
Fatty acid breakdown in the liver1 labelled palmitate, one hour after a single dose
Without BAM15 (comparison) 0%
With BAM15 51%

The mice did not move more, so the extra energy use does not come from more activity. Muscle and fat tissue showed no clear rise in respiration, BAM15 was distributed mainly to the liver.

Old obese mice, 10 weeks4

Difference from the group without BAM15 at the end, in percent (calculated from the means in the abstract)

Body weight4
Without BAM15 (comparison) 0.0%
With BAM15 -21.7%
Grip strength4
Without BAM15 (comparison) 0.0%
With BAM15 +37.1%
Distance moved4
Without BAM15 (comparison) 0.0%
With BAM15 +24.7%
Energy use per day4
Without BAM15 (comparison) 0.0%
With BAM15 +11.9%

Mice aged 80 weeks on a high-fat diet. The abstract gives the means of both groups (for example 54.0 versus 42.3 g body weight), the percentages are calculated from them. Muscle share of the body rose from 52.7 to 59.4 percent.

Glass model of a mitochondrion on a steel tray in the lab, two Petri dishes with blue liquid beside it, light steam above
So far only cell experiments and mouse models. Symbolic image.

Research status

Where the research stands

Where the compound stands on the way from lab research to approval. As of 25 Oct 2026. 8

  1. Preclinical Cell assays and mouse models since 2014
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 no registered trial
  5. Approval not yet
Not approved and no registered human trial. BAM15 has only been studied preclinically so far.8

So far there is no registered trial in humans. 8

Side effects

  • Body temperature: unchanged in mice, not studied in humans. As an uncoupler BAM15 releases energy as heat, so watch for overheating.
  • Elevated heart rate: reflects higher basal metabolic rate.
  • Sweating: classic uncoupling symptom.
  • Thirst: more fluid needed due to higher heat production.

Storage

Store dry and cool, out of reach of children.

Three white capsule bottles on a bright shelf next to a folded light blue towel
Store dry and cool, out of reach of children. Symbolic image.

Related

Related compounds

Same targets, blends with BAM15 or a different path: all in the TPD lexicon.

FAQ

Common questions about BAM15

Short answers, each backed by the sources below.

Is BAM15 approved or studied in humans?

No. There is no approval and as of 25 October 2026 the registry ClinicalTrials.gov lists no trial with BAM15. All data come from cell experiments and mouse models.87

How does BAM15 differ from DNP?

Both are protonophores, they let protons flow back into the mitochondria past ATP synthase. DNP also depolarises the outer cell membrane, BAM15 did not in the first study. In mouse liver cells BAM15 worked at a roughly sevenfold lower concentration and kept cell respiration high across a broad range. At higher concentrations DNP slowed respiration again.21

What do the mouse studies show on weight?

Mice made obese with a high-fat diet received BAM15 in their food for 5 weeks. They ate the same amount but weighed 15 percent less at the end, almost only through less fat. Lean mass stayed the same, the liver stored less fat and insulin action improved. A second group also saw protection from weight gain and better blood sugar. In their cell experiments BAM15 caused sustained activation of the energy enzyme AMPK.13

Does BAM15 raise body temperature?

Not in mice. Even high single doses did not change core temperature over 4 hours. As an uncoupler, though, BAM15 releases energy as heat. Whether this stays as calm in humans has not been studied.1

How long does BAM15 act and is it absorbed by mouth?

In mice 67 percent of an oral dose reached the blood and the half-life was 1.7 hours. Oxygen use stayed raised for about 3 hours after a single dose. For long-term experiments the researchers therefore mixed BAM15 into the food. There are no human data.1

What other findings are there?

In old obese mice weight fell over 10 weeks while muscle share and grip strength rose. In sepsis models more mice survived and the kidney took less damage. The first paper already saw protection from acute kidney injury. In a head-to-head comparison in mice with severe metabolic disease BAM15 and calorie restriction lowered weight and liver fat more than semaglutide.4526

Which side effects are known?

There are no solid data because BAM15 has never been tested in humans. In mice liver and kidney markers, blood counts and body temperature stayed normal. Mitochondrial uncouplers have historically had a narrow safety window and mouse data cannot rule that out.812

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

AMPK
The energy sensor of the cell. When energy runs short, AMPK switches the cell to burning sugar and fat.
ATP and ATP synthase
ATP is the energy currency of the cell. ATP synthase in the mitochondria makes it using the proton gradient.
Bioavailability
The share of a substance that actually reaches the blood after intake.
DNP
2,4-dinitrophenol, the oldest known uncoupler. Banned for human use in the USA since 1938 because of fatal overheating.
Half-life
The time until the amount in the blood has fallen by half.
Hyperthermia
Dangerous overheating of the body, the typical risk of older uncouplers.
Insulin sensitivity
How well cells respond to insulin. The better it is, the less insulin the body needs for the same blood sugar.
Mitochondria
Power plants of the cell. Inside them fat and sugar are turned into energy using oxygen.
Mitochondrial uncoupler
A substance that separates energy release in the mitochondria from ATP production. Energy from food is then lost as heat.
Plasma membrane
The outer envelope of the cell. If it is depolarised, the electrical charge of the cell is disturbed.
Preclinical
Research before first use in humans, in cell cultures and animal models. Results cannot be transferred directly to humans.
Protonophore
A molecule that carries protons across a membrane. This runs down the proton gradient of the mitochondria.

Evidence

Sources

Show all 9 sourcesHide sources 7 Studies1 Trial registry1 Database checked 25 Oct 2026

Studies

  1. BAM15 reverses diet-induced obesity and insulin resistance in mice

    Alexopoulos et al., Nature Communications, 2020

    Checked 25 Oct 2026 via doi.org, Crossref, PubMed, PMC (Volltext)
  2. First description: an uncoupler that spares the plasma membrane

    Kenwood et al., Molecular Metabolism, 2014

    Checked 25 Oct 2026 via doi.org, Crossref, PubMed
  3. BAM15 protects mice from obesity and improves blood sugar control

    Axelrod et al., EMBO Molecular Medicine, 2020

    Checked 25 Oct 2026 via doi.org, Crossref, PubMed
  4. Uncoupling in age-related sarcopenic obesity (mice)

    Dantas et al., Journal of Cachexia, Sarcopenia and Muscle, 2022

    Checked 25 Oct 2026 via doi.org, Crossref, PubMed
  5. BAM15 in sepsis and kidney injury (mice)

    Tsuji et al., Journal of Clinical Investigation, 2023

    Checked 25 Oct 2026 via doi.org, Crossref, PubMed
  6. Five approaches to metabolic disease compared head to head (mice)

    Chen et al., Biochimica et Biophysica Acta: Molecular Basis of Disease, 2024

    Checked 25 Oct 2026 via doi.org, Crossref, PubMed
  7. Review of BAM15 as an uncoupler

    Xiong et al., Frontiers in Endocrinology, 2023

    Checked 25 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Search on ClinicalTrials.gov (no trial with BAM15)

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 25 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. Structure of BAM15 in PubChem

    PubChem, U.S. National Library of Medicine (CID 565708)

    Checked 25 Oct 2026 via PubChem

In the shop

BAM15 in the catalog

Sizes, prices and shipping times are on the product page.

To the product